As of 12:25pm ET
| +0.05 / +1.40%|
The 5 analysts offering 12-month price forecasts for Achillion Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 10.00 and a low estimate of 3.50. The median estimate represents a +37.74% increase from the last price of 3.63.
The current consensus among 6 polled investment analysts is to Buy stock in Achillion Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.